GPC3 and hepatocellular carcinoma: Furthermore, FAT1, reported as a new glypican-3 (GPC3)-interacting protein, appeared as a relevant mediator of hypoxia and growth receptor signaling to critical tumorigenic pathways with a higher expression in HCC (16, 17).